Extracorporeal Membrane Oxygenation Market

Extracorporeal membrane oxygenation (ECMO) is a type of life support used when a person's heart and lungs are not working properly. ECMO takes blood out of body, sends it through devices to add oxygen and remove carbondioxide, and then pumps the blood back into body. This process provides temporary support, allowing the heart and lungs to rest and recover. ECMO is commonly used in critical care settings for conditions such as severe pneumonia, acute respiratory distress syndrome (ARDS), and cardiac arrest. It is typically categorized into two types, such as veno-arterial (VA) ECMO, which supports both heart and lung function, and veno-venous (VV) ECMO, which primarily supports lung function. While ECMO can be lifesaving, it is a complex procedure that requires continuous monitoring and is associated with potential risks, including bleeding, infection, and complications related to blood clotting.

The extracorporeal membrane oxygenation (ECMO) market is driven by rise in prevalence of respiratory and cardiac failures, fueled by conditions such as chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and heart failure. The increase in prevalence of respiratory diseases, particularly among aging population and critically ill patients, is boosting demand for ECMO systems as a life-saving intervention. In addition, rise in government initiatives and funding aimed at improving critical care infrastructure is also driving the market growth. Many countries are expanding ECMO programs in hospitals, increasing access to extracorporeal life support. Furthermore, rise in awareness among healthcare professionals about the advantages of ECMO in managing severe respiratory and cardiac conditions is leading to a greater adoption of the ECMO solutions. As more healthcare providers recognize its potential in saving lives and improving patient outcomes, the demand for ECMO systems continues to rise, thereby contributing to the growth of the market.

However, high costs associated with ECMO systems, including equipment, maintenance, and operational expenses, make it less accessible, particularly in developing regions, thereby restricting the market growth. The procedure requires highly trained healthcare professionals, and a shortage of skilled personnel limits its widespread adoption. On the other hand, innovations in portable and user-friendly ECMO systems are enhancing accessibility and efficiency, making them more viable for use in emergency and transport settings which provides an opportunity for the market growth.

The extracorporeal membrane oxygenation market is segmented into component, modulation, application, patient type, and region. By component, the market is segregated into controllers, pumps, oxygenator, cannula, and accessories. By modulation, the market is categorized into veno arterial (VA), veno venous (VV), and others. By application, the market is classified into cardiac diseases, respiratory disorders, and extracorporeal cardiopulmonary resuscitation. By patient type, the market is classified into neonates, pediatric, and adult. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, Russia, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, Thailand, Malaysia, Indonesia, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, UAE, Argentina, and Rest of LAMEA).

Major players that operate in the extracorporeal membrane oxygenation market are Medtronic plc, Terumo Corporation, Fresenius SE & Co. KGaA, Getinge, Microport Scientific Corporation, LivaNova, Inc., EUROSETS, CytoSorbents Corporation, Abbott Laboratories, and Chalice Medical Ltd. Key players have adopted product launch, agreement, collaboration, expansion, and product approval as key developmental strategies to improve the product portfolio of the extracorporeal membrane oxygenation market.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the extracorporeal membrane oxygenation market analysis from 2023 to 2035 to identify the prevailing extracorporeal membrane oxygenation market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the extracorporeal membrane oxygenation market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global extracorporeal membrane oxygenation market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Modulation

Others
Veno arterial
Veno venous

By Application

Cardiac Diseases
Respiratory Disorders
Extracorporeal Cardiopulmonary Resuscitation

By Patient Type

Neonates
Pediatric
Adult

By Component

Controllers
Pumps
Oxygenator
Cannula
Accessories

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Thailand
Malaysia
Indonesia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
UAE
Argentina
Rest of LAMEA
Key Market Players
Medtronic plc
Terumo Corporation
Eurosets
Getinge
Chalice Medical Ltd.
MicroPort Scientific Corporation
LivaNova PLC
CytoSorbents Corporation
Fresenius SE & Co. KGaA
Abbott LaboratoriesThe research methodology of the global market involves extensive primary and secondary research. Primary research includes about over 12 hours of interviews and discussion with a wide range of stakeholders, including upstream and downstream participants. The primary research typically is the bulk of our research efforts; however, coherently supported by extensive secondary research. Researchers have reviewed over 6,765 product literatures, industry releases, annual reports, and other such documents of key industry participants to obtain better market understanding and gain competitive intelligence. In addition, authentic industry journals, trade associations' releases,and government websites have also been reviewed for generating high-value industry insights. Show more